Justin Oldham
Associate Professor of Internal Medicine, Medical School
Office:
University of Michigan
1150 W. Medical Center Drive MSRBIII
Ann Arbor, Michigan 48109
1150 W. Medical Center Drive MSRBIII
Ann Arbor, Michigan 48109
Email:
[email protected]
Available to mentor
Justin Oldham
Associate Professor
Manage Your Profile
About
I am a pulmonary fibrosis specialist and director of the UM ILD program. As a PhD Epidemiologist and translational physician scientist, I conduct research aimed at developing blood-based biomarkers to accurately predict pulmonary fibrosis progression and treatment response.
Qualifications
-
FellowshipUniversity of Chicago, Chicago, United States
2011 - 2016
Postdoctoral Fellowship
-
ResidencyUniversity of California at Davis, USA
2006 - 2009
Residency
-
PhDUniversity of Michigan Medical School, Ann Arbor, United States
2022 - 2025
-
M.S.University of Chicago, United States
2014 - 2016
-
M.D., MedicineUniversity of Colorado, United States
2002 - 2006
-
B.A., HistoryUniversity of Colorado, United States
1997 - 2002
Center Memberships
-
Center MemberAI and Digital Health Innovation
Research Overview
Pulmonary fibrosis, proteomics, biomarkers, Epidemiology
Recent Publications
-
Wuyts WA, Richeldi L, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Martinez FJ, Valenzuela C, Wijsenbeek MS, Kanakapura M, James A, Weimann G, Drzewuski C, Coeck C, Maher TM. BMC Pulmonary Medicine, 2026 Dec 1; 26 (1):Journal ArticleDesign of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)
DOI:10.1186/s12890-025-03973-7 PMID: 41345848 -
Moen EV, Prior T, Kreuter M, Wuyts WA, Molina-Molina M, Wijsenbeek M, Møller J, Kronborg-White S, Østergård NM, Morais A, Tzouvelekis A, Ryerson CJ, Caro F, Buendia I, Magnusson J, Lee JS, Morisett J, Oldham JM, Troy LK, Funke-Chambour M, Alberti ML, Borie R, Walsh SLF, Rajan S, Kondoh Y, Khor YH, Bendstrup E. BMC Pulmonary Medicine, 2026 Dec 1; 26 (1):Journal ArticleGeographical, institutional and workplace variability in genetic evaluation, screening practices, multidisciplinary care, and lung transplantation management for familial interstitial lung disease
DOI:10.1186/s12890-026-04471-0 PMID: 42410570 -
Berger K, Konkol S, Ma SF, Whalen W, Simmons W, Joseph C, Noth I, Huang Y, Oldham J, Moskaluk CA, Lynch D, Humphries S, Kim JS, Podolanczuk AJ. Respiratory Research, 2026 Dec 1; 27 (1):Journal ArticlePCSK6 and clinical outcomes in the Pulmonary Fibrosis Foundation Patient Registry
DOI:10.1186/s12931-026-03642-1 PMID: 42010571 -
2026 Apr 13;PresentationPredicting ILD Progression with Precision
-
Lewis RJ, All Authors of “A statistical model for lung function trajectory and mortality in patients with fibrotic interstitial lung disease” . Am J Respir Crit Care Med, 2026 Oct 12;Journal ArticleReply to Lin et al.: Incorporating Mortality into the Longitudinal Analysis of Lung Function in Fibrotic Lung Disease.
DOI:10.1093/ajrccm/aamag556 PMID: 42865024 -
Podolanczuk AJ, Drake WP, Maher TM, Martinez FJ, Oldham JM, Sime PJ, Luo F. American Journal of Respiratory and Critical Care Medicine, 2026 Oct 1; 212 (10): 2288 - 2289.Journal ArticleFrom mechanisms to clinical practice: introduction to an AJRCCM special section on interstitial lung disease
DOI:10.1093/ajrccm/aamag433 PMID: 42608799 -
Pugashetti JV, Jee AS, Yu AR, Hammoud N, Chua F, Yazbeck L, Lee CT, Liu GY, Adams TN, Adegunsoye A, Wolters PJ, Khanna D, Strek ME, Oldham JM, Molyneaux PL, Newton CA. American Journal of Respiratory and Critical Care Medicine, 2026 Oct 1; 212 (10): 2493 - 2503.Journal ArticleMycophenolate and azathioprine in fibrotic interstitial lung disease
DOI:10.1093/ajrccm/aamag362 PMID: 42432856 -
Kim JS, Receveur B, Zhang D, Ma SF, Huang Y, McGroder C, Putman RK, Podolanczuk AJ, Rotter JI, Rich SS, Flaherty KR, Lee JS, Lasky JA, Raghu G, Murray S, Spino C, Martinez FJ, Oh A, Lynch DA, Humphries SM, Adegunsoye A, Oldham JM, Hunninghake GM, Garcia CK, Taub M, Mathias RA, Cho MH, Barr RG, Noth I, Mychaleckyj JC, Manichaikul A, Newton CA. American Journal of Respiratory and Critical Care Medicine, 2026 Oct 1; 212 (10): 2445 - 2454.Journal ArticlePerformance of age-adjusted whole genome sequencing telomere length in idiopathic pulmonary fibrosis
DOI:10.1093/ajrccm/aamag259 PMID: 42261270
Featured News & Stories
Department News
CME Event - Updates in the Diagnosis and Treatment of Interstitial Lung Disease
Join University of Michigan experts on Tuesday, January 27, 2026 from 2-3 pm for a free virtual panel discussion on the current updates in the diagnosis and treatment of interstitial lung disease.
